Risk adjusted net present value: What is the current valuation of Johnson & Johnson’s Nipocalimab?

Sanofi and Re­gen­eron are switch­ing up the fo­cus in their “Lung­Zone” cam­paign for Dupix­ent, this time high­light­ing asth­ma in chil­dren. This year’s dig­i­tal and video

When Lab­Cen­tral cel­e­brat­ed its 10th an­niver­sary last year, it was a bit­ter­sweet mo­ment. The in­cu­ba­tor has helped hun­dreds of biotechs launch and gain their foot­ing.